Charlotte Hodgkin

Cambridge University Hospitals NHS Foundation Trust

Papers

1

Total Citations

109

H-Index

1

About

Charlotte Hodgkin is a leading researcher in liquid biopsy and circulating tumor DNA (ctDNA) analysis, with a primary focus on the pre-analytical variables that underpin reproducible cancer diagnostics. Her most cited work, “Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients” (109 citations), is a seminal contribution that systematically demonstrated how blood collection tubes, processing delays, and centrifugation protocols dramatically alter cell-free DNA (cfDNA) yields from leukocyte lysis. By establishing rigorous pre-analytical standards, Hodgkin’s research has directly improved the sensitivity and specificity of ctDNA detection, enabling more reliable noninvasive cancer monitoring. Her work is foundational for clinical laboratories implementing liquid biopsy workflows, and she is recognized for bridging the critical gap between bench protocols and patient-ready assays. With a citation impact that underscores her influence in translational oncology, Hodgkin continues to shape best practices for ctDNA analysis, ensuring that the promise of personalized cancer management is built on a solid methodological foundation.

Research Focus

Key Achievements

1
H-Index
1
Papers
109
Total Citations
109
Avg Citations/Paper
🏆 Most Cited Paper
Effects of Collection and Processing Procedures on Plasma Circulating Cell-Free DNA from Cancer Patients
109 citations · 2018
📈 Most Prolific Year: 2018 (1 Papers)
🤝 Key Collaborators: 17
🏛 Institutions: Cambridge University Hospitals NHS Foundation Trust

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago